Skip to content
Tenfell
Upcoming
Published 22 Apr 2025

Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis System

NHS Blood and Transplant

Key facts

Estimated value
£100,000
Engagement closes
06 May 2025
Contract ends
31 Jul 2027
Buyer type
Health

Description

NHSBT would like to consult the market to establish the likely level of interest for the consumables and maintenance where Low Density Lipoprotein removal is performed on Fresenius Medical Care (UK) Ltd. ART Universal machines at the following sites: Bristol and Leeds. NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services from 11 dedicated units across England and Wales.

Categories (CPV)

Similar open tenders

About NHS Blood and Transplant

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.